The present study also showed that JR has the ability to inhibit the activation of Akt, ERK, JNK and p38 MAPK, suggesting that JR may suppress TGFβ1-induced EMT expression and thereby migration and invasion of hepatoma cells via Smad-dependent and Smad-independent pathways. The gene discussed is AKT1; the disease is hepatocellular carcinoma.